CD244 represents a new therapeutic target in head and neck squamous cell carcinoma

CD244 represents a new therapeutic target in head and neck squamous cell carcinoma

Background Developing novel strategies to overcome the immunosuppressive tumor microenvironment is a critically important area of cancer therapy research. Here, we assess the therapeutic potential of CD244 (2B4/signaling lymphocyte activation molecule family 4), an immunoregulatory receptor found on...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Conforti, Laura Agresta, Maria Lehn, Kristin Lampe, Rachel Cantrell, Cassandra Hennies, Sara Szabo, Trisha Wise-Draper, Kasper Hoebe, Edith M Janssen
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000245.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items